A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Indian Pharma Eyes Major Gains as US BIOSECURE Act Targets Chinese Biotech

Unpacking Today's Market Movers: A Closer Look at Stocks Capturing Attention

Dr. Reddy's Unveils Breakthrough Solution for Acid-Related GI Woes in India

Market Movers: Unpacking the Buzz Around Top Stocks Today

Dr. Reddy's Powers Up Talent with Fresh ESOP Share Allotment

A New Era for Actinic Keratosis Treatment: Extrovis and Dr. Reddy's Unveil Authorized Generic of CARAC® Cream